186 related articles for article (PubMed ID: 26943608)
1. Analytical issues of serum free light chain assays and the relative performance of polyclonal and monoclonal based reagents.
Carr-Smith HD; Jenner EL; Evans JA; Harding SJ
Clin Chem Lab Med; 2016 Jun; 54(6):997-1003. PubMed ID: 26943608
[TBL] [Abstract][Full Text] [Related]
2. Measurement of free light chains with assays based on monoclonal antibodies.
Te Velthuis H; Drayson M; Campbell JP
Clin Chem Lab Med; 2016 Jun; 54(6):1005-14. PubMed ID: 27010775
[TBL] [Abstract][Full Text] [Related]
3. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
[TBL] [Abstract][Full Text] [Related]
4. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
[TBL] [Abstract][Full Text] [Related]
5. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
Kennard A; Hawley C; Tate J; Klingberg S; Pretorius C; Hutchison C; Mollee P
Clin Chem Lab Med; 2016 Jun; 54(6):1045-52. PubMed ID: 26684350
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots.
Pretorius CJ; Klingberg S; Tate J; Wilgen U; Ungerer JP
Ann Clin Biochem; 2012 Sep; 49(Pt 5):450-5. PubMed ID: 22764186
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
9. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
Levinson SS
Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
[TBL] [Abstract][Full Text] [Related]
12. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
[TBL] [Abstract][Full Text] [Related]
14. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Free Light Chain Assays: Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis.
Mahmood S; Wassef NL; Salter SJ; Sachchithanantham S; Lane T; Foard D; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Am J Clin Pathol; 2016 Jul; 146(1):78-85. PubMed ID: 27353767
[TBL] [Abstract][Full Text] [Related]
16. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
Morales-García LJ; Pacheco-Delgado MS
Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
[TBL] [Abstract][Full Text] [Related]
18. A multicentre study comparing two methods for serum free light chain analysis.
Lock RJ; Saleem R; Roberts EG; Wallage MJ; Pesce TJ; Rowbottom A; Cooper SJ; McEvoy ED; Taylor JL; Basu S
Ann Clin Biochem; 2013 May; 50(Pt 3):255-61. PubMed ID: 23605135
[TBL] [Abstract][Full Text] [Related]
19. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
Bradwell AR; Carr-Smith HD; Mead GP; Tang LX; Showell PJ; Drayson MT; Drew R
Clin Chem; 2001 Apr; 47(4):673-80. PubMed ID: 11274017
[TBL] [Abstract][Full Text] [Related]
20. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
